Compare UIS & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UIS | ANIK |
|---|---|---|
| Founded | 1942 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.4M | 192.4M |
| IPO Year | 1994 | 1996 |
| Metric | UIS | ANIK |
|---|---|---|
| Price | $2.37 | $14.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.67 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 952.4K | 130.2K |
| Earning Date | 05-26-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,950,100,000.00 | $112,819,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | $2.60 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.11 | $7.90 |
| 52 Week High | $5.33 | $17.10 |
| Indicator | UIS | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 74.67 |
| Support Level | $2.11 | $9.43 |
| Resistance Level | $2.65 | N/A |
| Average True Range (ATR) | 0.12 | 0.70 |
| MACD | 0.03 | 0.17 |
| Stochastic Oscillator | 46.67 | 85.98 |
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.